@andrewk65 good questions and exactly the topics I had in mind.
regarding the CR for commercialization of burn treatment; yes there could be good ways of executing it that way on a smaller scale. as usual its about how management explains the details, communicates to shareholders and how it is linked with institutions being involved. As soon as there are major institutions involved, then I get very sceptical.
For me ideally it would be a CR with only management and existing shareholders participating. That would be ideal IMO. Keep the sharks out...
For Sepsis I would prefer them to partner big time and address it on a global scale.
(20min delay)